InSight+·3 min read·medium
Asthma experts explain key asthma topics in quick updates
✦AI Summary
The National Asthma Council Australia has released updated guidelines to help clinicians improve asthma management, noting that many patients rely too heavily on short-acting beta 2 agonists. The updates emphasize that these 'blue puffers' do not treat the underlying cause of asthma and that better management is needed to prevent hospitalizations.
print Share: (Credit - National Asthma Council)
healtheducation
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in